Those that have been following FDA’s activity regarding dietary supplements containing N-acetyl-L-cysteine (NAC) are likely happy to see some movement in the right direction. FDA just issued its draft guidance regarding their intent to exercise regulatory discretion allowing products to remain in commerce pending their final decision on the status of NAC as a recognized dietary supplement ingredient.
With FDA’s …